QR-koodi

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Täydet tiedot

Tallennettuna:
Päätekijät: Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Journal of Infection in Developing Countries 2024-05-01
Sarja:Journal of Infection in Developing Countries
Aiheet:
Chronic HCV infection
hepatocellular carcinoma
liver cirrhosis
direct-acting antiviral agents
Linkit:https://jidc.org/index.php/journal/article/view/18410
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia